• With foresighted strategic decisions, Tchaikapharma ensured unprecedented access to therapies for 2 million Bulgarians during the pandemic

    April 4, 2022


    The pandemic has caused problems in the forefront of predictability and access to medicines in the country. It was difficult to supply the basic (active) substances for pharmaceutical production, and a slight increase in the production of drugs.


    In this context, even before the first global lockdown, the team of Tchaikapharma has prepared a stategy for action in the unprecedented situation, by defining three main challenges.


    The full article is available here in Bulgarian.